Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Luxembourg
Office for Official Publ. of the Europ. Communities
1999
|
| Schlagworte: | |
| Beschreibung: | 94 S. graph. Darst. |
| ISBN: | 929168063X |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV012670038 | ||
| 003 | DE-604 | ||
| 005 | 20221216 | ||
| 007 | t| | ||
| 008 | 990720s1999 lu d||| |||| 10||| eng d | ||
| 016 | 7 | |a 957641133 |2 DE-101 | |
| 020 | |a 929168063X |9 92-9168-063-X | ||
| 024 | 8 | |a <<EU Katalognr.:>> AO 22 99 143 EN C | |
| 035 | |a (OCoLC)231784433 | ||
| 035 | |a (DE-599)BVBBV012670038 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 044 | |a lu |c XA-LU | ||
| 049 | |a DE-12 |a DE-384 |a DE-355 |a DE-521 |a DE-188 | ||
| 050 | 0 | |a RM301.9.E94 1999a | |
| 084 | |a MK 5200 |0 (DE-625)123071: |2 rvk | ||
| 084 | |a MS 6410 |0 (DE-625)123754: |2 rvk | ||
| 084 | |a PS 3884 |0 (DE-625)139813: |2 rvk | ||
| 245 | 1 | 0 | |a Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs |c EMCDDA, European Monitoring Centre for Drugs and Drug Addiction |
| 264 | 1 | |a Luxembourg |b Office for Official Publ. of the Europ. Communities |c 1999 | |
| 300 | |a 94 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 610 | 2 | 7 | |a Europäische Union |0 (DE-588)5098525-5 |2 gnd |9 rswk-swf |
| 650 | 7 | |a Droghe - consumo - aspetti fisiologici |2 sbt | |
| 650 | 7 | |a Droghe - consumo - aspetti giuridici |2 sbt | |
| 650 | 7 | |a Ecstasy - consumo - Europa |2 sbt | |
| 650 | 4 | |a Politik | |
| 650 | 4 | |a Drug monitoring -- Government policy -- European Union countries | |
| 650 | 4 | |a Designer drugs -- European Union countries | |
| 650 | 4 | |a Synthetic drugs -- European Union countries | |
| 650 | 0 | 7 | |a Gesundheitsgefährdung |0 (DE-588)4071808-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Drogenmissbrauch |0 (DE-588)4070587-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Metamfetamin |0 (DE-588)4191463-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Toxizität |0 (DE-588)4078372-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Drogenpolitik |0 (DE-588)4140775-1 |2 gnd |9 rswk-swf |
| 651 | 4 | |a Europäische Union. Mitgliedsstaaten | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Metamfetamin |0 (DE-588)4191463-6 |D s |
| 689 | 0 | 1 | |a Toxizität |0 (DE-588)4078372-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Europäische Union |0 (DE-588)5098525-5 |D b |
| 689 | 1 | 1 | |a Metamfetamin |0 (DE-588)4191463-6 |D s |
| 689 | 1 | 2 | |a Drogenmissbrauch |0 (DE-588)4070587-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Drogenmissbrauch |0 (DE-588)4070587-0 |D s |
| 689 | 2 | 1 | |a Metamfetamin |0 (DE-588)4191463-6 |D s |
| 689 | 2 | 2 | |a Gesundheitsgefährdung |0 (DE-588)4071808-6 |D s |
| 689 | 2 | |8 1\p |5 DE-604 | |
| 689 | 3 | 0 | |a Europäische Union |0 (DE-588)5098525-5 |D b |
| 689 | 3 | 1 | |a Metamfetamin |0 (DE-588)4191463-6 |D s |
| 689 | 3 | 2 | |a Drogenpolitik |0 (DE-588)4140775-1 |D s |
| 689 | 3 | |8 2\p |5 DE-604 | |
| 710 | 2 | |a Europäische Kommission |b Beobachtungsstelle für Drogen und Drogensucht |e Sonstige |0 (DE-588)5079600-8 |4 oth | |
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-008610507 | |
Datensatz im Suchindex
| _version_ | 1820127979736399872 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV012670038 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.9.E94 1999a |
| callnumber-search | RM301.9.E94 1999a |
| callnumber-sort | RM 3301.9 E94 41999A |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | MK 5200 MS 6410 PS 3884 |
| ctrlnum | (OCoLC)231784433 (DE-599)BVBBV012670038 |
| discipline | Rechtswissenschaft Politologie Soziologie |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV012670038</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20221216</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">990720s1999 lu d||| |||| 10||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">957641133</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">929168063X</subfield><subfield code="9">92-9168-063-X</subfield></datafield><datafield tag="024" ind1="8" ind2=" "><subfield code="a"><<EU Katalognr.:>> AO 22 99 143 EN C</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231784433</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012670038</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">lu</subfield><subfield code="c">XA-LU</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-384</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.9.E94 1999a</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MK 5200</subfield><subfield code="0">(DE-625)123071:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MS 6410</subfield><subfield code="0">(DE-625)123754:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PS 3884</subfield><subfield code="0">(DE-625)139813:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs</subfield><subfield code="c">EMCDDA, European Monitoring Centre for Drugs and Drug Addiction</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Luxembourg</subfield><subfield code="b">Office for Official Publ. of the Europ. Communities</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">94 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Droghe - consumo - aspetti fisiologici</subfield><subfield code="2">sbt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Droghe - consumo - aspetti giuridici</subfield><subfield code="2">sbt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ecstasy - consumo - Europa</subfield><subfield code="2">sbt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug monitoring -- Government policy -- European Union countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Designer drugs -- European Union countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Synthetic drugs -- European Union countries</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsgefährdung</subfield><subfield code="0">(DE-588)4071808-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogenmissbrauch</subfield><subfield code="0">(DE-588)4070587-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Metamfetamin</subfield><subfield code="0">(DE-588)4191463-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Toxizität</subfield><subfield code="0">(DE-588)4078372-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogenpolitik</subfield><subfield code="0">(DE-588)4140775-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Europäische Union. Mitgliedsstaaten</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Metamfetamin</subfield><subfield code="0">(DE-588)4191463-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Toxizität</subfield><subfield code="0">(DE-588)4078372-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Metamfetamin</subfield><subfield code="0">(DE-588)4191463-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Drogenmissbrauch</subfield><subfield code="0">(DE-588)4070587-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Drogenmissbrauch</subfield><subfield code="0">(DE-588)4070587-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Metamfetamin</subfield><subfield code="0">(DE-588)4191463-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Gesundheitsgefährdung</subfield><subfield code="0">(DE-588)4071808-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Metamfetamin</subfield><subfield code="0">(DE-588)4191463-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Drogenpolitik</subfield><subfield code="0">(DE-588)4140775-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Europäische Kommission</subfield><subfield code="b">Beobachtungsstelle für Drogen und Drogensucht</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5079600-8</subfield><subfield code="4">oth</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008610507</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| geographic | Europäische Union. Mitgliedsstaaten |
| geographic_facet | Europäische Union. Mitgliedsstaaten |
| id | DE-604.BV012670038 |
| illustrated | Illustrated |
| indexdate | 2025-01-02T09:15:06Z |
| institution | BVB |
| institution_GND | (DE-588)5079600-8 |
| isbn | 929168063X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008610507 |
| oclc_num | 231784433 |
| open_access_boolean | |
| owner | DE-12 DE-384 DE-355 DE-BY-UBR DE-521 DE-188 |
| owner_facet | DE-12 DE-384 DE-355 DE-BY-UBR DE-521 DE-188 |
| physical | 94 S. graph. Darst. |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Office for Official Publ. of the Europ. Communities |
| record_format | marc |
| spelling | Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs EMCDDA, European Monitoring Centre for Drugs and Drug Addiction Luxembourg Office for Official Publ. of the Europ. Communities 1999 94 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Europäische Union (DE-588)5098525-5 gnd rswk-swf Droghe - consumo - aspetti fisiologici sbt Droghe - consumo - aspetti giuridici sbt Ecstasy - consumo - Europa sbt Politik Drug monitoring -- Government policy -- European Union countries Designer drugs -- European Union countries Synthetic drugs -- European Union countries Gesundheitsgefährdung (DE-588)4071808-6 gnd rswk-swf Drogenmissbrauch (DE-588)4070587-0 gnd rswk-swf Metamfetamin (DE-588)4191463-6 gnd rswk-swf Toxizität (DE-588)4078372-8 gnd rswk-swf Drogenpolitik (DE-588)4140775-1 gnd rswk-swf Europäische Union. Mitgliedsstaaten (DE-588)1071861417 Konferenzschrift gnd-content Metamfetamin (DE-588)4191463-6 s Toxizität (DE-588)4078372-8 s DE-604 Europäische Union (DE-588)5098525-5 b Drogenmissbrauch (DE-588)4070587-0 s Gesundheitsgefährdung (DE-588)4071808-6 s 1\p DE-604 Drogenpolitik (DE-588)4140775-1 s 2\p DE-604 Europäische Kommission Beobachtungsstelle für Drogen und Drogensucht Sonstige (DE-588)5079600-8 oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs Europäische Union (DE-588)5098525-5 gnd Droghe - consumo - aspetti fisiologici sbt Droghe - consumo - aspetti giuridici sbt Ecstasy - consumo - Europa sbt Politik Drug monitoring -- Government policy -- European Union countries Designer drugs -- European Union countries Synthetic drugs -- European Union countries Gesundheitsgefährdung (DE-588)4071808-6 gnd Drogenmissbrauch (DE-588)4070587-0 gnd Metamfetamin (DE-588)4191463-6 gnd Toxizität (DE-588)4078372-8 gnd Drogenpolitik (DE-588)4140775-1 gnd |
| subject_GND | (DE-588)5098525-5 (DE-588)4071808-6 (DE-588)4070587-0 (DE-588)4191463-6 (DE-588)4078372-8 (DE-588)4140775-1 (DE-588)1071861417 |
| title | Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs |
| title_auth | Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs |
| title_exact_search | Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs |
| title_full | Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs EMCDDA, European Monitoring Centre for Drugs and Drug Addiction |
| title_fullStr | Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs EMCDDA, European Monitoring Centre for Drugs and Drug Addiction |
| title_full_unstemmed | Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs EMCDDA, European Monitoring Centre for Drugs and Drug Addiction |
| title_short | Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs |
| title_sort | report on the risk assessment of mbdb in the framework of the joint action on new synthetic drugs |
| topic | Europäische Union (DE-588)5098525-5 gnd Droghe - consumo - aspetti fisiologici sbt Droghe - consumo - aspetti giuridici sbt Ecstasy - consumo - Europa sbt Politik Drug monitoring -- Government policy -- European Union countries Designer drugs -- European Union countries Synthetic drugs -- European Union countries Gesundheitsgefährdung (DE-588)4071808-6 gnd Drogenmissbrauch (DE-588)4070587-0 gnd Metamfetamin (DE-588)4191463-6 gnd Toxizität (DE-588)4078372-8 gnd Drogenpolitik (DE-588)4140775-1 gnd |
| topic_facet | Europäische Union Droghe - consumo - aspetti fisiologici Droghe - consumo - aspetti giuridici Ecstasy - consumo - Europa Politik Drug monitoring -- Government policy -- European Union countries Designer drugs -- European Union countries Synthetic drugs -- European Union countries Gesundheitsgefährdung Drogenmissbrauch Metamfetamin Toxizität Drogenpolitik Europäische Union. Mitgliedsstaaten Konferenzschrift |
| work_keys_str_mv | AT europaischekommissionbeobachtungsstellefurdrogenunddrogensucht reportontheriskassessmentofmbdbintheframeworkofthejointactiononnewsyntheticdrugs |